QUIMATRYX DEVELOPS AN EFFECTIVE EPIGENETIC DRUG AGAINST MANTLE CELL LYMPHOMA

QUIMATRYX has developed an epigenetic drug that has shown great efficacy in animal models against Mantle Cell Lymphoma.

https://lymphomanewstoday.com/2018/06/21/qtx125-slows-mantle-cell-lymphoma-progression-mouse-study/